Atorvastatin effectively inhibits late replicative cycle steps of SARS-CoV-2 in vitro
M. I. Zapata-Cardona, L. Florez-Alvarez, W. Zapata-Builes, A. Guerra-Sandoval, C. Guerra-Almonacid, J. Hincapie-Garcia, M. T. Rugeles, J. C. Hernandez
This paper evaluates atorvastatin's in vitro antiviral effect against SARS-CoV-2, showing inhibition of late replicative cycle steps and favorable binding affinity with viral proteins.
bioRxiv · Mar 1, 2021 · PreprintMicrobiology